Capital Fund Management »

Mineralys Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 102k 27.09

More positions owned by Capital Fund Management

Tesla Tesla Inc Com (TSLA)
Micron Technology Micron Technology Inc Com (MU)
Apple Apple Inc Com (AAPL)
Microsoft Corp Microsoft Corp Com (MSFT)
Taiwan Semiconductor Manufac Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Chevron Corporation Chevron Corporation Com (CVX)
Amazon Amazon Com Inc Com (AMZN)
Eli Lilly & Co Eli Lilly & Co Com (LLY)
Palantir Technologies Inc Cl A Palantir Technologies Inc Cl A (PLTR)
Citigroup Citigroup Inc Com New (C)
Berkshire Hathaway Inc Del Cl B Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ge Aerospace Ge Aerospace Com New (GE)
Meta Platforms Inc Cl A Meta Platforms Inc Cl A (META)
Advanced Micro Devices Advanced Micro Devices Inc Com (AMD)
Lam Research Corp Lam Research Corp Com New (LRCX)

View all positions for Capital Fund Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
FMR
BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Caption Management
OrbiMed Advisors
Point72 Asset Management
Franklin Resources
Boothbay Fund Management
Laurion Capital Management

View all funds holding Mineralys Therapeutics